China Resources Boya Bio-pharmaceutical Group Co.,Ltd (SHE:300294)

China · Delayed Price · Currency is CNY

21.21

+0.58 (2.81%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Inter-Segment Elimination	-3.55M	-	-	-23.72M	-20.22M
Biochemical Pharmaceutical Product	211.84M	335.11M	-	510.94M	634.48M
Biochemical Pharmaceutical Product Growth	-36.78%	-	-	-19.47%	-29.68%
Pharmaceutical Distribution Business	2.02M	757.80M	-	663.63M	639.71M
Pharmaceutical Distribution Business Growth	-99.73%	-	-	3.74%	-0.41%
Other Business	10.17M	9.94M	-	29.77M	25.92M
Other Business Growth	2.32%	-	-	14.84%	107.84%
Blood Products Business	1.51B	1.45B	-	1.23B	912.88M
Blood Products Business Growth	4.32%	-	-	34.96%	-7.59%
Diabetes Medicine Business	-	97.44M	-	237.89M	320.26M
Diabetes Medicine Business Growth	-	-	-	-25.72%	-11.96%
Total	1.73B	2.65B	-	2.65B	2.51B
Total Growth	-34.58%	-	-	5.47%	-13.60%

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015
Mainland China	1.73B	2.65B	2.76B	2.65B	2.51B
Mainland China Growth	-34.58%	-3.87%	4.08%	5.47%	-13.60%
Total	1.73B	2.65B	2.76B	2.65B	2.51B
Total Growth	-34.58%	-3.87%	4.08%	5.47%	-13.60%

Source: S&P Global Market Intelligence.